# Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

> **NCT00467636** · NA · TERMINATED · sponsor: **The Royal Bournemouth Hospital** · enrollment: 51 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Hyperglycemia

## Interventions

- **PROCEDURE:** Blood glucose monitoring
- **DRUG:** Insulin Glulisine

## Key facts

- **NCT ID:** NCT00467636
- **Lead sponsor:** The Royal Bournemouth Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Difficulty recruiting (early discharge scheme initiated)
- **Last updated:** 2009-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467636, "Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00467636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*